Skip to content

prevention and treatment study of Chinese traditional medicine on psychological diseases

prevention and treatment study of Chinese traditional medicine on psychological diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002524
Enrollment
Unknown
Registered
2012-09-16
Start date
2010-09-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychological diseases

Interventions

Traditional Chinese medicine group:Chinese herbs
The western medicine group:Estazolam
Traditional Chinese medicine and psychotherapy gro:Chinese herbs and psychotherapy
The western medicine and psychotherapy group:Estazolam and psychotherapy
The western medicine group:Vin Rafa Sin hydrochloride
Traditional Chinese medicine group:XiLening
Placebo group:Placebo
Traditional Chinese medicine and psychotherapy gro:XiLening and psychotherapy
The western medicine and psychotherapy group:Vin Rafa Sin hydrochloride and psychotherapy
Traditional Chinese medicine group:Chinese herbs and Donepezil hydrochloride simulati
The western medicine group:Chinese herbs and Donepezil hydrochloride simulati

Sponsors

Guang’anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Insomnia inclusion criteria: 1. with integrated traditional Chinese and Western medicine diagnosis standard of insomnia, and in accordance with the heart of courage deficiency syndrome diagnostic criteria; 2. the age 18-65 years old; 3. the course of more than 2 weeks; 4. volunteering to participate in, and sign the informed consent. Depression into standard: 1. age: 18-65 years old, male or female; 2. with the western depression (depressive episodes) diagnostic criteria and phlegm syndrome of liver stagnation and spleen deficiency type standard; 3. group HAMD Depression Scale total scores >=17, and less than 24 points; 4. group HAMA Anxiety Scale total score=14, and less than 29 points; 4. group HAMD Depression Scale score<=7; 5. informed consent and signed informed consent.Signed the informed consent.

Exclusion criteria

Exclusion criteria: Insomnia exclusion criteriaExclusion criteria 1. does not meet the criteria for the diagnosis of heart of courage or insomnia asthenia syndrome classification standard; 2. in pregnant and lactating women; 3. has a mental illness patients with severe or suicidal patients. Depression exclusion criteria1, there is the tendency of suicide; 2. severe anxiety (HAMA score >21 points); 3. secondary to other psychiatric or somatic disease and severe depressive episode with psychotic symptoms; 4. bipolar disorder, treatment-resistant depression (using 2 or more different chemical structure of antidepressants, with adequate, enough course of treatment is invalid or ineffective); 5. combined with other severe diseases, and the severity of heart, liver, renal dysfunction (including ALT, AST higher than the normal value of 1.5 times.); 6. the group around taking antidepressants; 7. pregnancy or lactation or pseudo pregnancy in women of childbearing age; a positive urinary pregnancy test; 8. the known alcohol or drug dependence. Anxiety disorder exclusion criteria1, there is the tendency of suicide; 2. severe anxiety ( HAMA score >29 points); 3. secondary to other psychiatric or somatic disorders anxiety attack and with severe psychotic symptoms; 4. combined with other severe diseases, and the severity of heart, liver, renal dysfunction (including ALT, AST higher than the normal value of 1.5 times.).

Design outcomes

Primary

MeasureTime frame
Psychological indices;Sleep index; PSQI, PSG;Cerebral function index: MRI/fMR;

Countries

China

Contacts

Public ContactWang Weidong
prof_wwd@126.com+86 10 88001261

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026